Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Carboplatin

  • You have access
    Pretreatment Platelet Count and Neutrophil/Lymphocyte Ratio Are Predictive Markers for Carboplatin Plus Pemetrexed Therapy-induced Thrombocytopenia
    MASAYA TAKAHASHI, KATSUYUKI TAKAHASHI, HIROYASU KANEDA, TOMOYA KAWAGUCHI and KATSUYA NAGAYAMA
    Anticancer Research November 2021, 41 (11) 5729-5737; DOI: https://doi.org/10.21873/anticanres.15389
  • You have access
    Serum Proteomic Profiling Reveals Differentially Expressed IGHG3 and A1AG1 as Potential Predictors of Chemotherapeutic Response in Advanced Non-small Cell Lung Cancer
    MAY MYAT MON, CHANTRAGAN SRISOMSAP, DARANEE CHOKCHAICHAMNANKIT, KAMOLWAN WATCHARATANYATIP, CHURAT WEERAPHAN, JISNUSON SVASTI, KAJORNKIAT MANEECHAI, PARAMEE THONGSUKSAI and PRITSANA RAUNGRUT
    Anticancer Research April 2021, 41 (4) 1871-1882; DOI: https://doi.org/10.21873/anticanres.14953
  • You have access
    Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Ovarian Cancer Cells In Vitro
    TEA KUITTINEN, PÄIVI ROVIO, TIINA LUUKKAALA, MARITA LAURILA, SEIJA GRÉNMAN, ANNE KALLIONIEMI and JOHANNA MÄENPÄÄ
    Anticancer Research June 2020, 40 (6) 3129-3138; DOI: https://doi.org/10.21873/anticanres.14294
  • You have access
    Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study
    ANGIOLO GADDUCCI, STEFANIA COSIO, ANDREA ALBERTO LISSONI, VALENTINA ZIZIOLI, MARCO ADORNI, ANNA MARIA FERRERO, FABIO LANDONI and ENRICO SARTORI
    Anticancer Research March 2020, 40 (3) 1543-1550; DOI: https://doi.org/10.21873/anticanres.14100
  • You have access
    Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer
    KAZUHISA NAKASHIMA, HIROAKI AKAMATSU, HARUYASU MURAKAMI, TAKASHI NIWA, YASUO IWAMOTO, YUICHI OZAWA, TOSHIHIDE YOKOYAMA, HIROYASU SHODA, NOBUYUKI YAMAMOTO, HIROSHIGE YOSHIOKA, KEN MASUDA, TATEAKI NAITO, KEITA MORI and TOSHIAKI TAKAHASHI
    Anticancer Research March 2019, 39 (3) 1463-1468; DOI: https://doi.org/10.21873/anticanres.13263
  • You have access
    TTF-1 Expression Predicts the Merit of Additional Antiangiogenic Treatment in Non-squamous Non-small Cell Lung Cancer
    AKIRA TAKEUCHI, TETSUYA OGURI, YORIKO YAMASHITA, KAZUKI SONE, SATOSHI FUKUDA, OSAMU TAKAKUWA, TAKEHIRO UEMURA, KEN MAENO, KENSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, HIROTSUGU OHKUBO, MASAYA TAKEMURA, YUTAKA ITO and AKIO NIIMI
    Anticancer Research September 2018, 38 (9) 5489-5495; DOI: https://doi.org/10.21873/anticanres.12882
  • You have access
    Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIs
    SATOSHI WATANABE, OU YAMAGUCHI, AI MASUMOTO, YURI MAENO, YOSUKE KAWASHIMA, OSAMU ISHIMOTO, SHUNICHI SUGAWARA, HIROHISA YOSHIZAWA, TOSHIAKI KIKUCHI, TOSHIHIRO NUKIWA and KUNIHIKO KOBAYASHI
    Anticancer Research August 2018, 38 (8) 4699-4704; DOI: https://doi.org/10.21873/anticanres.12776
  • You have access
    Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients
    HIROAKI TAKEOKA, KAZUHIKO YAMADA, YOSHIKO NAITO, NORIKAZU MATSUO, HIDENOBU ISHII, TAKAAKI TOKITO, KOICHI AZUMA, MASAO ICHIKI and TOMOAKI HOSHINO
    Anticancer Research June 2018, 38 (6) 3779-3784; DOI: https://doi.org/10.21873/anticanres.12661
  • You have access
    Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells In Vitro
    TEA KUITTINEN, PÄIVI ROVIO, SYNNÖVE STAFF, TIINA LUUKKAALA, ANNE KALLIONIEMI, SEIJA GRÉNMAN, MARITA LAURILA and JOHANNA MÄENPÄÄ
    Anticancer Research December 2017, 37 (12) 6575-6581;
  • You have access
    Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility
    GIOVANNI SCHINZARI, SANTA MONTERISI, FRANCESCO PIERCONTI, GIULIA NAZZICONE, LAURA MARANDINO, ARMANDO ORLANDI, MARCO RACIOPPI, ALESSANDRA CASSANO, PIERFRANCESCO BASSI, CARLO BARONE and ERNESTO ROSSI
    Anticancer Research November 2017, 37 (11) 6453-6458;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire